About

The Drögemöller Lab uses large-scale genomic and computational analyses to guide the development of novel treatment strategies that offer maximum benefit and minimal harm.

This research is focused specifically on vulnerable and understudied populations (e.g. pediatric and maternal populations) as therapeutic agents are often not designed and tested with these patients in mind.

Principal Investigator

Dr. Britt Drögemöller is an Assistant Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba. Dr. Drögemöller holds a Canada Research Chair in Pharmacogenomics and Precision Medicine and is appointed as a Research Scientist at The Children’s Hospital Foundation of Manitoba and an Adjunct Scientist in the Research Institute in Oncology and Hematology.

Dr. Drögemöller received her PhD from Stellenbosch University in South Africa in 2013. She continued her training in pharmacogenomics and precision medicine at the University of British Columbia, where she completed a postdoctoral fellowship at the Canadian Pharmacogenomics Network for Drug Safety.

MSc student

MacKenzie Sarvis is a MSc student in the Department of Biochemistry & Medical Genetics at the University of Manitoba. MacKenzie has graduated with her BSc (Hons) in Genetics from the University of Manitoba in 2020. She completed an undergraduate thesis on identifying genes associated with autism spectrum disorder through Hardy-Weinberg disequilibrium and her MSc project will focus on developing a polygenic risk score in order to aid with the prediction and prevention of cisplatin-induced ototoxicity.

Honours Student

Sarah is an undergrad student at the Univeristy of Manitoba currently pursing a Genetic Honours Co-op degree. Under the supervision of Dr. Drögemöller she is studying genetic variants associated with polycystic ovary syndrome and their role in treatment outcomes of patients.